{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:25:40Z","timestamp":1784157940629,"version":"3.55.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL152724"],"award-info":[{"award-number":["R01HL152724"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL152724"],"award-info":[{"award-number":["R01HL152724"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Pulmonary arterial hypertension (PAH) is a heterogeneous disease within a complex diagnostic and treatment environment. Other complex heart and lung diseases have substantial regional variation in characteristics and outcomes; however, this has not been previously described in PAH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To identify baseline differences between U.S. census regions in the characteristics and outcomes for participants in the Pulmonary Hypertension Association Registry (PHAR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adults with PAH were divided into regional groups (Northeast, South, Midwest, and West), and baseline differences between census regions were presented. Kaplan-Meier survival analyses and Cox proportional hazards were used to estimate the association between region and mortality in unadjusted and adjusted models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Substantial differences by census regions were seen in age, race, ethnicity, marital status, employment, insurance payor breakdown, active smoking, and current alcohol use. Differences were also seen in PAH etiology and baseline 6-minute walk distance test results. Treatment characteristics varied by census region, and mortality appeared to be lower in PHAR participants in the West (hazard ratio, 0.60; 95% confidence interval, 0.43\u20130.83, P\u2009=\u20090.005). This difference was not readily explained by differences in demographic characteristics, PAH etiology, baseline severity, baseline medication regimen, or disease prevalence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The present study suggests significant regional variation among participants at accredited pulmonary vascular disease centers in multiple baseline characteristics and mortality. This variation may have implications for clinical research planning and represent an important focus for further study to better understand whether there are remediable care aspects that can be addressed in the pursuit of providing equitable care in the United States.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202305-424oc","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T17:00:13Z","timestamp":1694192413000},"page":"1718-1725","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":13,"title":["Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association Registry"],"prefix":"10.1093","volume":"20","author":[{"given":"Connor","family":"Fling","sequence":"first","affiliation":[{"name":"Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"De Marco","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of California, San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah A.","family":"Kime","sequence":"additional","affiliation":[{"name":"Department of Biostatistics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Lammi","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Louisiana State University, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Oppegard","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Oregon Health Sciences University, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Ryan","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey E.","family":"Ventetuolo","sequence":"additional","affiliation":[{"name":"Department of Medicine and"},{"name":"Department of Health Services, Policy & Practice, Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1399-5206","authenticated-orcid":false,"given":"R. James","family":"White","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and"},{"name":"the Mary M. Parkes Center, University of Rochester, Rochester, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roham T.","family":"Zamanian","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Stanford University, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5716-248X","authenticated-orcid":false,"given":"Peter J.","family":"Leary","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, and"},{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"2026012203294164000_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/diseases10010005","article-title":"Comparing diagnosis and treatment of pulmonary hypertension patients at a pulmonary hypertension center versus community centers","volume":"10","author":"Saunders","year":"2022","journal-title":"Diseases"},{"key":"2026012203294164000_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012203294164000_bib3","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2026012203294164000_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpeds.2015.11.012","article-title":"The geographic impact on hospitalization in patients with cystic fibrosis","volume":"170","author":"Kopp","year":"2016","journal-title":"J Pediatr"},{"key":"2026012203294164000_bib5","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.chest.2021.04.010","article-title":"Survival and lung transplant outcomes for individuals with advanced cystic fibrosis lung disease living in the United States and Canada: an analysis of national registries","volume":"160","author":"Ramos","year":"2021","journal-title":"Chest"},{"key":"2026012203294164000_bib6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1513\/AnnalsATS.202007-774OC","article-title":"Clinical differences and outcomes between methamphetamine-associated and idiopathic pulmonary arterial hypertension in the Pulmonary Hypertension Association Registry","volume":"18","author":"Kolaitis","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203294164000_bib7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1513\/AnnalsATS.202011-1415ED","article-title":"Regional variation in methamphetamine-associated pulmonary arterial hypertension: who\u2019d better call Saul?","volume":"18","author":"Prohaska","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203294164000_bib8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.chest.2016.10.043","article-title":"Pulmonary hypertension care center network: improving care and outcomes in pulmonary hypertension","volume":"151","author":"Sahay","year":"2017","journal-title":"Chest"},{"key":"2026012203294164000_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.21693\/1933-088X-16.4.185","article-title":"The Pulmonary Hypertension Association Registry: rationale, design, and role in quality improvement","volume":"16","author":"Gray","year":"2018","journal-title":"Adv Pulm Hypertens"},{"key":"2026012203294164000_bib10","year":"2021"},{"key":"2026012203294164000_bib11","doi-asserted-by":"crossref","first-page":"2000414","DOI":"10.1183\/13993003.00414-2020","article-title":"EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR","volume":"57","author":"Borgese","year":"2021","journal-title":"Eur Respir J"},{"key":"2026012203294164000_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.chest.2020.08.2069","article-title":"Development and validation of an abridged version of the REVEAL 2.0 risk score calculator, REVEAL Lite 2, for use in patients with pulmonary arterial hypertension","volume":"159","author":"Benza","year":"2021","journal-title":"Chest"},{"key":"2026012203294164000_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780195314465.001.0001","volume-title":"Epidemiologic methods: studying the occurrence of illness","author":"Weiss","year":"2014","edition":"2nd ed"},{"key":"2026012203294164000_bib14","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1513\/AnnalsATS.202109-1051OC","article-title":"Hispanic ethnicity and social determinants of health in pulmonary arterial hypertension: the Pulmonary Hypertension Association Registry","volume":"19","author":"Bernardo","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203294164000_bib15","doi-asserted-by":"crossref","first-page":"e12120","DOI":"10.1002\/pul2.12120","article-title":"Prediction of patient outcomes through social determinants of health: the Pulmonary Hypertension Association Registry (PHAR) evaluation","volume":"12","author":"Grinnan","year":"2022","journal-title":"Pulm Circ"},{"key":"2026012203294164000_bib16","doi-asserted-by":"crossref","first-page":"e026940","DOI":"10.1161\/JAHA.122.026940","article-title":"Social determinants of cardiovascular health: a longitudinal analysis of cardiovascular disease mortality in US counties from 2009 to 2018","volume":"12","author":"Son","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026012203294164000_bib17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.chest.2018.11.030","article-title":"Therapy for pulmonary arterial hypertension in adults: update of the CHEST guideline and expert panel report","volume":"155","author":"Klinger","year":"2019","journal-title":"Chest"},{"key":"2026012203294164000_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.socscimed.2015.10.052","article-title":"Beyond inequality: acknowledging the complexity of social determinants of health","volume":"147","author":"Eckersley","year":"2015","journal-title":"Soc Sci Med"},{"key":"2026012203294164000_bib19","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jamainternmed.2013.319","article-title":"Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study","volume":"173","author":"Dea\u00f1o","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2026012203294164000_bib20","doi-asserted-by":"crossref","first-page":"e12020","DOI":"10.1002\/pul2.12020","article-title":"Prevalence, incidence, and survival of pulmonary arterial hypertension: a systematic review for the Global Burden of Disease 2020 study","volume":"12","author":"Emmons-Bell","year":"2022","journal-title":"Pulm Circ"},{"key":"2026012203294164000_bib21","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/ALN.0000000000000834","article-title":"Regional and gender differences and trends in the anesthesiologist workforce","volume":"123","author":"Baird","year":"2015","journal-title":"Anesthesiology"},{"key":"2026012203294164000_bib22","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/archinte.161.19.2351","article-title":"Variation in routine electrocardiogram use in academic primary care practice","volume":"161","author":"Stafford","year":"2001","journal-title":"Arch Intern Med"},{"key":"2026012203294164000_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMsa0910881","article-title":"Regional variations in diagnostic practices","volume":"363","author":"Song","year":"2010","journal-title":"N Engl J Med"},{"key":"2026012203294164000_bib24","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1158\/1055-9965.EPI-12-0207","article-title":"The inconvenience of convenience cohorts: rhabdomyosarcoma and the PAX-FOXO1 biomarker","volume":"21","author":"Rosenberg","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026012203294164000_bib25","first-page":"e31764","article-title":"Characteristics of patients with pulmonary arterial hypertension in a Pulmonary Hypertension Association-accredited comprehensive care center: a contrast in features when compared with US national registry data","volume":"14","author":"Ingram","year":"2022","journal-title":"Cureus"},{"key":"2026012203294164000_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.108.809707","article-title":"Optimizing trial design: sequential, adaptive, and enrichment strategies","volume":"119","author":"Mehta","year":"2009","journal-title":"Circulation"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/20\/12\/1718\/66267620\/annalsats_20_12_1718.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/20\/12\/1718\/66267620\/annalsats_20_12_1718.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:31:35Z","timestamp":1769070695000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/20\/12\/1718\/8414398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12,1]]},"published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202305-424oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"2023-05-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}